New clues to how lymphatic malformations develop

Hirose KATSUTOSHI, Satoshi TOYOSAWA
Department of Oral and Maxillofacial Pathology

 A research team led by the Graduate School of Dentistry at the University of Osaka has revealed shared disease mechanisms across patients, pointing to a potential new therapeutic pathway.

Lymphatic malformations are rare disorders in which lymph vessels develop abnormally, often beginning in childhood and sometimes causing swelling, infection, bleeding, pain, or airway obstruction. a research group led by the Graduate School of Dentistry at the University of Osaka have combined genetic analysis with detailed examination of patient tissues to uncover common features of the disease and identify molecular clues that could inform future treatment strategies.

The team analyzed tissue samples from 34 patients. Changes in the PIK3CA gene, which are known to contribute to abnormal lymphatic vessel growth, were detected in 20 patients, or 58.8%. Most clinical features were similar whether a mutation was detected, but malformed vessels showed a more scattered growth pattern in patients carrying PIK3CA mutations.

They also found that a major cell-growth signaling system, the PI3K/AKT/mTOR pathway, was more active in malformed lymphatic vessels than in normal vessels regardless of PIK3CA mutation status. AKT activity also increased with patient age. These findings are consistent with the clinical effectiveness of sirolimus, a drug that targets this pathway, across patients with lymphatic malformations.

To search for additional disease-related molecules, the team performed spatial transcriptomic analysis in two PIK3CA-mutant cases. Ten genes were commonly more active in malformed lymphatic vessels. Among them, NFATC1 was strongly expressed in the endothelial cells lining malformed lymphatic vessels. The findings suggest that the calcineurin-NFAT pathway may also contribute to the disease pathogenesis and could represent a future therapeutic target.

“We succeeded in providing a more integrated view of lymphatic malformations, from genetic changes to pathological morphology and molecular activity. We hope that this may help refine existing treatments while guiding the search for new ones,” says first author Katsutoshi HIROSE.

【Journal Information】
Title: Comprehensive Molecular and Clinicopathological Profiling of Lymphatic Malformations
Journal: Laboratory Investigation
DOI: https://doi.org/10.1016/j.labinv.2026.106168